Results 161 to 170 of about 394,456 (275)
Long-term adverse effects following COVID-19 vaccination: A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines. [PDF]
Aldali JA, Meo SA.
europepmc +1 more source
Nuevos estudios de antropología criminal
Agustín Avrial exerce ca. 1840-1898La España Moderna exerce ca.
Ferri, Enrique
core
Historia general de la literatura
Ed. Gonblanc es seudónimo de Edmundo González BlancoYeves Andrés, Juan Antonio. La España Moderna: catálogo de la editorial, índice de las revistas. Madrid 2002. P. 144, da como fecha probable de publicación para esta ed.
Gonblanc, Ed
core
ABSTRACTBackgroundIn Australia, non‐pharmaceutical interventions introduced early in 2020 to curtail the spread of COVID‐19 resulted in the temporary elimination of influenza. We used data from this influenza‐free period (2021) to validate influenza mortality burden predictions from time‐series models.MethodsTime‐series models were parameterised with ...
Jessie J. Goldsmith +4 more
wiley +1 more source
Safety and Immunogenicity of an mRNA Respiratory Syncytial Virus Vaccine, mRNA-1345, in Healthy and High-Risk Pediatric Populations Aged 2 to 17 Years. [PDF]
Moore J +7 more
europepmc +1 more source
Título: La corona de olivo silvestre
La España Moderna edita ca. 1889-1922Agustín Avrial trabaja ca. 1840-1898Datos del impresor: Agustín Avrial traballa ca.
Ruskin, John, 1819-1900
core
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern +14 more
wiley +1 more source
Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies. [PDF]
Freyn AW +12 more
europepmc +1 more source
Yeves Andrés, Juan Antonio. La España Moderna: catálogo de la editorial, índice de las revistas. Madrid 2002. P. 95, da como fecha probable de publicación para esta ed. ca.
Haussonville Comtesse de
core
ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) is a rare, progressive cholangiopathy for which diagnosis remains challenging because of the absence of disease‐specific markers and the presence of secondary causes of sclerosing cholangitis (SSC) that closely mimic its clinical presentation. Diagnostic uncertainty can delay appropriate
Miki Scaravaglio +20 more
wiley +1 more source

